Patent · US Active

Enone reductases

US9388438B2 · kind B2 · utility

4Cited by
9References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2015
Grant dateJul 12, 2016
Priority date
Expiry dateJul 15, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure relates to engineered enone reductase polypeptides having improved properties, polynucleotides encoding the engineered polypeptides, related vectors, host cells, and methods for making the engineered enone reductase polypeptides. The disclosure also provides methods of using the engineered enone reductase polypeptides for chemical transformations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.